Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years

Authors:

Abstract
Frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases with common genetic causes, the most frequent being a GGGGCC repeat expansion in the chromosome 9 open reading frame 72 (C9orf72) gene.1,2 This expansion may lead to a loss of C9orf72 function and causes abnormal neuronal aggregation of nuclear RNA foci, dipeptides repeats (DPR), and transactive response DNA-binding protein 43 (TDP-43) inclusions.3 Recent preclinical development of disease-modifying drugs, such as antisense oligonucleotides that target mutant RNA, offer promising therapeutic perspectives in C9orf72 disease.4,5

This publication has 43 references indexed in Scilit: